VEMIX
Price
$29.23
Change
+$0.04 (+0.14%)
Updated
Feb 21 closing price
Net Assets
109.55B
WIEMX
Price
$2.75
Change
-$0.05 (-1.79%)
Updated
Feb 21 closing price
Net Assets
267.36M
Ad is loading...

VEMIX vs WIEMX

Header iconVEMIX vs WIEMX Comparison
Open Charts VEMIX vs WIEMXBanner chart's image
Vanguard Emerging Mkts Stock Idx Instl
Price$29.23
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets109.55B
Wasatch Emerging Markets Small Cap Instl
Price$2.75
Change-$0.05 (-1.79%)
VolumeN/A
Net Assets267.36M
VEMIX vs WIEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VEMIX vs. WIEMX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEMIX is a Buy and WIEMX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 110B vs. WIEMX (267M). VEMIX pays higher dividends than WIEMX: VEMIX (3.46) vs WIEMX (0.00). VEMIX was incepted earlier than WIEMX: VEMIX (25 years) vs WIEMX (9 years). WIEMX is a more actively managed with annual turnover of: 21.00 vs. VEMIX (5.00). WIEMX has a lower initial minimum investment than VEMIX: WIEMX (100000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 13.44 vs. WIEMX (-8.94). VEMIX return over 5 years is better than : 17.83 vs. WIEMX (-6.86).
VEMIXWIEMXVEMIX / WIEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years9 years-
Gain YTD4.399-3.169-139%
Front LoadN/AN/A-
Min. Initial Investment50000001000005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets110B267M41,199%
Annual Yield % from dividends3.460.00-
Returns for 1 year13.44-8.94-150%
Returns for 3 years2.02-24.66-8%
Returns for 5 years17.83-6.86-260%
Returns for 10 years31.51N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SR75.071.13
+1.53%
Spire
LH249.850.68
+0.27%
Laboratory Corp
CAPL22.87-0.38
-1.63%
CrossAmerica Partners LP
EGAN5.09-0.10
-1.93%
eGain Corp
NEUP4.88-0.17
-3.37%
Neuphoria Therapeutics Inc